Abstract
Apoptosis is a stage-dependent process exhibiting characteristic biochemical, molecular and morphological features that vary progressively through the apoptosis process. Apoptosis induced by toxicants may activate varied features of apoptosis to different extents and kinetics. Some of the features activated may occur transiently, while others may not occur in a cell system undergoing toxicant-induced apoptosis. Thus, the best approach for quantitating the extent of toxicant-induced apoptosis involves the utilization of a combination of assays focusing on different morphological, biochemical and molecular features of apoptosis. The kinetics of the apoptosis process will also need to be studied in any cell system subjected to toxicant-induced apoptosis for the first time, especially when more than one compound (such as an apoptosis inducing agent and an inhibitor) is being utilized. The use of multiple concurrent and phased apoptosis assays will streamline the process of determining the extent of apoptosis in such systems. Thus, in this report, we describe the concurrent use of an early, intermediate, and late apoptosis assay in order to measure different biochemical and morphological properties of apoptosis in the same system. We demonstrate the usefulness of the concurrent phased apoptosis assays using human TK6 lymphoblasts undergoing diepoxbutane-induced apoptosis. Additional notes, as well as tips for modifying the protocol for adherent cells, are included.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Li K, Wu D, Chen X, Zhang T, Zhang L, Yi Y, Miao Z, Jin N, Bi X, Wang H, Xu J, Wang D (2014) Current and emerging biomarkers of cell death in human disease. Biomed Res Int 2014:690103
Goldar S, Khaniani MS, Derakhshan SM, Baradaran B (2015) Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev 16:2129–2144
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516
Tower J (2015) Programmed cell death in aging. Ageing Res Rev 23:90–100
Zeng W, Wang X, Xu P, Liu G, Eden HS, Chen X (2015) Molecular imaging of apoptosis: from micro to macro. Theranostics 5:559–582
Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nunez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19:107–120
Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Campanella M, Candi E, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, Di Daniele N, Dixit VM, Dynlacht BD, El-Deiry WS, Fimia GM, Flavell RA, Fulda S, Garrido C, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Joseph B, Jost PJ et al (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 22:58–73
Ulukaya E, Acilan C, Yilmaz Y (2011) Apoptosis: why and how does it occur in biology? Cell Biochem Funct 29:468–480
Fuchs Y, Steller H (2011) Programmed cell death in animal development and disease. Cell 147:742–758
Shalini S, Dorstyn L, Dawar S, Kumar S (2015) Old, new and emerging functions of caspases. Cell Death Differ 22:526–539
Kanemura S, Tsuchiya A, Kanno T, Nakano T, Nishizaki T (2015) Phosphatidylinositol induces caspase-independent apoptosis of malignant pleural mesothelioma cells by accumulating AIF in the nucleus. Cell Physiol Biochem 36:1037–1048
Rello-Varona S, Herrero-Martin D, Lopez-Alemany R, Munoz-Pinedo C, Tirado OM (2015) “(Not) all (dead) things share the same breath”: identification of cell death mechanisms in anticancer therapy. Cancer Res 75:913–917
Kim YE, Chen J, Chan JR, Langen R (2010) Engineering a polarity-sensitive biosensor for time-lapse imaging of apoptotic processes and degeneration. Nat Methods 7:67–73
Kim YE, Chen J, Langen R, Chan JR (2010) Monitoring apoptosis and neuronal degeneration by real-time detection of phosphatidylserine externalization using a polarity-sensitive indicator of viability and apoptosis. Nat Protoc 5:1396–1405
Bucur O, Stancu AL, Khosravi-Far R, Almasan A (2012) Analysis of apoptosis methods recently used in cancer research and cell death & disease publications. Cell Death Dis 3, e263
Hankins HM, Baldridge RD, Xu P, Graham TR (2015) Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution. Traffic 16:35–47
Leventis PA, Grinstein S (2010) The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 39:407–427
Schlegel RA, Williamson P (2001) Phosphatidylserine, a death knell. Cell Death Differ 8:551–563
Wu H, Che X, Zheng Q, Wu A, Pan K, Shao A, Wu Q, Zhang J, Hong Y (2014) Caspases: a molecular switch node in the crosstalk between autophagy and apoptosis. Int J Biol Sci 10:1072–1083
Nicholls SB, Hyman BT (2014) Measuring caspase activity in vivo. Methods Enzymol 544:251–269
McStay GP, Green DR (2014) Measuring apoptosis: caspase inhibitors and activity assays. Cold Spring Harb Protoc 2014:799–806
Novus-Biologicals (2014) pSIVA-IANBD Apoptosis/Viability Microscopy Set Product Information and Manual
Promega (2015) Caspase-Glo 3/7 Technical Bulletin.
Squier MK, Cohen JJ (2001) Standard quantitative assays for apoptosis. Mol Biotechnol 19:305–312
Yadavilli S, Muganda PM (2004) Diepoxybutane induces caspase and p53-mediated apoptosis in human lymphoblasts. Toxicol Appl Pharmacol 195:154–165
Yadavilli S, Chen Z, Albrecht T, Muganda PM (2009) Mechanism of diepoxybutane-induced p53 regulation in human cells. J Biochem Mol Toxicol 23:373–386
Jackson MA, Stack HF, Rice JM, Waters MD (2000) A review of the genetic and related effects of 1,3-butadiene in rodents and humans. Mutat Res 463:181–213
Yadavilli S, Martinez-Ceballos E, Snowden-Aikens J, Hurst A, Joseph T, Albrecht T, Muganda PM (2007) Diepoxybutane activates the mitochondrial apoptotic pathway and mediates apoptosis in human lymphoblasts through oxidative stress. Toxicol In Vitro 21:1429–1441
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ewunkem, A.J., Muganda, P.M. (2016). Determining the Extent of Toxicant-Induced Apoptosis Using Concurrent Phased Apoptosis Assays. In: Muganda, P. (eds) Apoptosis Methods in Toxicology. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3588-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3588-8_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3586-4
Online ISBN: 978-1-4939-3588-8
eBook Packages: Springer Protocols